Induction of antigen-specific immunity in human neonates and infants

Nestle Nutrition Workshop Series: Pediatric Program

Volumn 61, Issue , 2008, Pages 183-193

  Wilson, C ^a   Kollmann, T ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOBACTERIUM BOVIS BCG;

ANTIBODY PRODUCTION; B LYMPHOCYTE; CELLULAR IMMUNITY; DENDRITIC CELL; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; NEWBORN; PHYSIOLOGY; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANTIBODY FORMATION; B-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNITY, CELLULAR; INFANT; INFANT, NEWBORN; MALE; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 42449150930     PISSN: 16616677     EISSN: 16623878     Source Type: Book Series    
DOI: 10.1159/000113493     Document Type: Conference Paper

References (34)

1. Klein JO, Remington JS, Baker CJ, Wilson CB: Current concepts of infections of the fetus and newborn infant; in Remington JS, Klein JO, Baker CJ, Wilson CB (eds): Infectious Diseases of the Fetus and Newborn Infant, ed 6. Philadelphia, Elsevier Saunders, 2006, pp 3-25.
2. Lewis DB, Wilson CB (eds): Developmental Immunology and Role of Host Defenses in Fetal and Neonatal Susceptibility to Infection, ed 6. Philadelphia, Elsevier Saunders, 2006.
3. Siegrist CA: Vaccination in the neonatal period and early infancy. Int Rev Immunol 2000;19:195-219.
4. Marchant A, Goldman M: T cell-mediated immune responses in human newborns: ready to learn? Clin Exp Immunol 2005;141:10-18.
5. Schneider P: The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol 2005;17:282-289.
6. Pulendran B, Ahmed R: Translating innate immunity into immunological memory: implications for vaccine development. Cell 2006;124:849-863.
7. Gans H, DeHovitz R, Forghani B, et al: Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine 2003;21:3398-3405.
8. Weaver CT, Harrington LE, Mangan PR, et al: Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006;24:677-688.
9. Burchett SK, Corey L, Mohan KM, et al: Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J Infect Dis 1992;165:813-818.
10. Pass RF, Stagno S, Britt WJ, Alford CA: Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. J Infect Dis 1983;148:953-961.
11. Tu W, Chen S, Sharp M, et al: Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J Immunol 2004;172:3260-3267.
12. Mascart F, Verscheure V, Malfroot A, et al: Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses. J Immunol 2003;170:1504-1509.
13. Marchant A, Appay V, Van Der Sande M, et al: Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest 2003;111:1747-1755.
14. Hermann E, Truyens C, Alonso-Vega C, et al: Human fetuses are able to mount an adultlike CD8 T-cell response. Blood 2002;100:2153-2158.
15. Scott ZA, Chadwick EG, Gibson LL, et al: Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infants. J Immunol 2001;167:7134-7140.
16. Vekemans J, Ota MO, Wang EC, et al: T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination. Clin Exp Immunol 2002;127:495-498.
17. Ota MO, Vekemans J, Schlegel-Haueter SE, et al: Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults. Vaccine 2004;22:511-519.
18. Rowe J, Macaubas C, Monger T, et al: Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic th1 function. J Infect Dis 2001;184:80-88.
19. Ota MO, Vekemans J, Schlegel-Haueter SE, et al: Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J Immunol 2002;168:919-925.
20. Murray RA, Mansoor N, Harbacheuski R, et al: Bacillus Calmette Guérin vaccination of human newborns induces a specific, functional CD8+ T cell response. J Immunol 2006;177:5647-5651.
21. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE: Nod-like proteins in immunity, inflammation and disease. Nat Immunol 2006;7:1250-1257.
22. De Wit D, Olislagers V, Goriely S, et al: Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 2004;103:1030-1032.
23. Drohan L, Harding JJ, Holm B, et al: Selective developmental defects of cord blood antigen-presenting cell subsets. Hum Immunol 2004;65:1356-1369.
24. De Wit D, Tonon S, Olislagers V, et al: Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J Autoimmun 2003;21:277-281.
25. Gold MC, Donnelly E, Cook MS, et al: Purified neonatal plasmacytoid dendritic cells overcome intrinsic maturation defect with TLR agonist stimulation. Pediatr Res 2006;60:34-37.
26. Cederblad B, Riesenfeld T, Alm GV: Deficient herpes simplex virus-induced interferon-alpha production by blood leukocytes of preterm and term newborn infants. Pediatr Res 1990;27:7-10.
27. Goriely S, Vincart B, Stordeur P, et al: Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol 2001;166:2141-2146.
28. Langrish CL, Buddle JC, Thrasher AJ, Goldblatt D: Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol 2002;128:118-123.
29. Upham JW, Lee PT, Holt BJ, et al: Development of interleukin-12-producing capacity throughout childhood. Infect Immun 2002;70:6583-6588.
30. Latz E, Franko J, Golenbock DT, Schreiber JR: Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity. J Immunol 2004;172:2431-2438.
31. Granoff DM, Anderson EL, Osterholm MT, et al: Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J Pediatr 1992;121:187-194.
32. Keyserling HL, Wickliffe C: Abstract 63. 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta. Washington, American Society for Microbiology, 1990.
33. Ward JI, et al: Abstract 984. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim. Washington, American Society for Microbiology, 1992.
34. Lieberman JM, Greenberg DP, Wong VK, et al: Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines. J Pediatr 1995;126:198-205.